Study Stopped
lack of recruitment
Outcome of Old Patient With Articular With Articular Implant Infection
OPWAI
1 other identifier
interventional
3
1 country
1
Brief Summary
Articular Implant Infection (AII) is itself a complicated diagnosis and a challenging condition to treat. In elderly patients, the application of existing recommendations is impeded by multiple frailties For a better knowledge of the long-term consequences of AII in elderly patient, the investigators conduct a prospective, multicentric study, whitch aim this is to better evaluate the burden of AII on elderly patients, in terms of quality of life. Secondly, the investigators would like to identify the factors that influence the prognosis, in order to guide further prospective research.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Mar 2021
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 3, 2021
CompletedFirst Submitted
Initial submission to the registry
September 24, 2021
CompletedFirst Posted
Study publicly available on registry
March 17, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 28, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
March 28, 2023
CompletedMarch 30, 2023
March 1, 2023
2.1 years
September 24, 2021
March 28, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Changes in the EQ-5D-5L quality of life score
the EQ-5D-5L questionnaire is a European quality of life scale: a first part with questions called "EQ-5D descriptive system" comprising 5 items: mobility, self-care, usual activities, pain and discomfort, anxiety and depression; each item is rated from 1 to 5; 1 corresponding to "no problem", "5" representing "extreme problems or total disability Changes in the EQ-5D-5L quality of life score, 1 year after the onset of symptoms will be evaluated
1 year
Changes in the EQ-5D-VAS assessing the patient's general condition, completed by the patient
the EQ-5D-5L questionnaire is completed by a visual analogue scale, called "EQ-5D VAS"; it consists of a 20 cm line, graduated from 0 to 100, where the patient has to indicate how he/she evaluates his/her current state of health, 0 being the worst possible state and 100 the best; Changes in the "EQ-5D VAS" wil be evaluated 1 year after the onset of symptoms.
1 year
Study Arms (1)
follow-up visit at 6 months and 1 year after inclusion.
OTHERaddition of a follow-up visit at 6 months and 1 year after inclusion. No treatment will be given specifically for this study. Other visits are part of the normal and usual rhythm of follow-up and evaluation of treatment in these patients
Interventions
Addition of an additional follow-up visit 6 months post infection and one follow-up visit 1 year post infection. No treatment will be given specifically for this study. The change in medical management will only be modified by the addition of these 2 consultations at 6 months and 1 year post infection
Eligibility Criteria
You may qualify if:
- hospitalized in infectious diseases, surgery, post-emergency unit, or geriatrics,
- diagnosed with a hip or knee prosthesis infection in the previous month according to the SPILF criteria (2009)(1).
You may not qualify if:
- Above criteria not met,
- Patient refusal,
- Mild cognitive impairment or more significant.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Centre Hospitalier Métropole Savoie
Chambéry, 73000, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
PEJU Martin, Physician
Centre Hospitalier Metropole Savoie
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 24, 2021
First Posted
March 17, 2022
Study Start
March 3, 2021
Primary Completion
March 28, 2023
Study Completion
March 28, 2023
Last Updated
March 30, 2023
Record last verified: 2023-03